Plant based API sales will expand through 2036, with amino acids at 43.2% within the product type segment and pharmaceuticals at 52.1% of the distribution channel category in 2026. The market is estimated at USD 4.2 billion in 2026 and is forecast to record a 6.4% CAGR between 2026 and 2036.